Novel anthracycline analogs
- PMID: 2272029
- DOI: 10.1016/0305-7372(90)90037-g
Novel anthracycline analogs
Similar articles
-
Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.Jpn J Cancer Res. 1985 Oct;76(10):1008-20. Jpn J Cancer Res. 1985. PMID: 3935619
-
[Modulation of anthracycline resistance by reserpine in P388 leukemia cells].Nihon Yakurigaku Zasshi. 1991 Jul;98(1):1-6. doi: 10.1254/fpj.98.1_1. Nihon Yakurigaku Zasshi. 1991. PMID: 1889760 Japanese.
-
[Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I].Bioorg Khim. 2008 May-Jun;34(3):430-2. doi: 10.1134/s1068162008030230. Bioorg Khim. 2008. PMID: 18672696 Russian.
-
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.Invest New Drugs. 1985;3(1):3-21. doi: 10.1007/BF00176819. Invest New Drugs. 1985. PMID: 3886588 Review.
-
Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.Cancer Treat Rep. 1983 Oct;67(10):895-9. Cancer Treat Rep. 1983. PMID: 6354437 Review.
Cited by
-
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.Br J Cancer. 1992 May;65(5):703-7. doi: 10.1038/bjc.1992.148. Br J Cancer. 1992. PMID: 1586598 Free PMC article.
-
Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR.Invest New Drugs. 1994;12(2):93-7. doi: 10.1007/BF00874437. Invest New Drugs. 1994. PMID: 7860237
-
Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.Br J Cancer. 1994 Jul;70(1):79-84. doi: 10.1038/bjc.1994.253. Br J Cancer. 1994. PMID: 8018545 Free PMC article.
-
Engineered biosynthesis of aklanonic acid analogues.J Am Chem Soc. 2005 Sep 7;127(35):12254-62. doi: 10.1021/ja051429z. J Am Chem Soc. 2005. PMID: 16131203 Free PMC article.
-
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.Br J Cancer. 1999 Mar;79(7-8):1067-73. doi: 10.1038/sj.bjc.6690171. Br J Cancer. 1999. PMID: 10098738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources